- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Endocrinology
Volume 2011 (2011), Article ID 867475, 4 pages
Thyrotoxic Periodic Paralysis: Case Reports and an Up-to-Date Review of the Literature
1Department of Endocrinology, South London HealthCare NHS Trust, Orpington Hospital, Sevenoaks Road, Orpington BR6 9JU, UK
2Department of Endocrinology, Whittington NHS Trust Hospital, London N19 5NF, UK
Received 4 June 2011; Accepted 20 July 2011
Academic Editors: G. Aimaretti, K. Kasagi, L. Meyer, and W. V. Moore
Copyright © 2011 Abbi Lulsegged et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Y. J. Hsu, Y. F. Lin, T. Chau, J. T. Liou, S. W. Kuo, and S. H. Lin, “Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis,” The American Journal of the Medical Sciences, vol. 326, no. 3, pp. 128–132, 2003.
- S. L. Venance, S. C. Cannon, D. Fialho et al., “The primary periodic paralyses: diagnosis, pathogenesis and treatment,” Brain, vol. 129, no. 1, pp. 8–17, 2006.
- T. Ai, Y. Fujiwara, K. Tsuji et al., “Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia,” Circulation, vol. 105, no. 22, pp. 2592–2594, 2002.
- C. W. Lu, J. H. Lin, Y. S. Rajawat et al., “Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome,” Journal of Medical Genetics, vol. 43, no. 8, pp. 653–659, 2006.
- A. J. McFadzean and R. Yeung, “Periodic paralysis complicating thyrotoxicosis in Chinese,” The British Medical Journal, vol. 1, no. 538, pp. 451–455, 1967.
- R. C. Reisin, O. Martinez, M. Moran et al., “Thyrotoxic periodic paralysis in caucasians. Report of 8 cases,” Neurologia, vol. 15, no. 6, pp. 222–225, 2000.
- C. Chatot-Henry, D. Smadja, R. Longhi, A. Brebion, and G. Sobesky, “Thyrotoxic periodic paralysis. Two news cases in black race patients,” Revue de Medecine Interne, vol. 21, no. 7, pp. 632–634, 2000.
- S. R. Mehta, A. Verma, H. Malhotra, and S. Mehta, “Normokalaemic periodic paralysis as the presenting manifestation of hyperthyroidism,” Journal of the Association of Physicians of India, vol. 38, no. 4, pp. 296–297, 1990.
- L. Lam, R. J. Nair, and L. Tingle, “Thyrotoxic periodic paralysis,” Proceedings (Baylor University. Medical Center), vol. 19, no. 2, pp. 126–129, 2006.
- L. Forrest and J. Platts, “Ecstasy-induced thyrotoxic periodic paralysis,” BMJ Case Reports, bcr0920092280, 2009.
- M.-J. Hsieh, R.-K. Lyu, W.-N. Chang et al., “Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks,” The European Journal of Neurology, vol. 15, no. 6, pp. 559–564, 2008.
- S. Wongraoprasert, P. Buranasupkajorn, V. Sridama, and T. Snabboon, “Thyrotoxic periodic paralysis induced by pulse methylprednisolone,” Internal Medicine, vol. 46, no. 17, pp. 1431–1434, 2007.
- D. Shulkin, B. R. Olson, and G. S. Levey, “Thyrotoxic periodic paralysis in a Latin-American taking acetazolamide,” The American Journal of the Medical Sciences, vol. 297, no. 5, pp. 337–338, 1989.
- S. Chaudhury, F. Ismail-Beigi, G. G. Gick, R. Levenson, and I. S. Edelman, “Effect of thyroid hormone on the abundance of Na,K-adenosine triphosphatase α-subunit messenger ribonucleic acid,” Molecular Endocrinology, vol. 1, no. 1, pp. 83–89, 1987.
- V. M. S. Oh, E. A. Taylor, S.-H. Yeo, and K.-O. Lee, “Cation transport across lymphocyte plasma membranes in euthyroid and thyrotoxic men with and without hypokalaemic periodic paralysis,” Clinical Science, vol. 78, no. 2, pp. 199–206, 1990.
- M. Guerra, A. Rodriguez del Castillo, E. Battaner, and M. Mas, “Androgens stimulate preoptic area Na+K+-ATPase activity in male rats,” Neuroscience Letters, vol. 78, no. 1, pp. 97–100, 1987.
- S. Soonthornpun, W. Setasuban, and A. Thamprasit, “Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP),” Clinical Endocrinology, vol. 70, no. 5, pp. 794–797, 2009.
- A. Chan, R. Shinde, C. C. Chow, C. S. Cockram, and R. Swaminathan, “Hyperinsulinaemia and Na+, K+-ATPase activity in thyrotoxic periodic paralysis,” Clinical Endocrinology, vol. 41, no. 2, pp. 213–216, 1994.
- A. W. Kung, “Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 7, pp. 2490–2495, 2006.
- S. H. Lin, P. Chu, C. J. Cheng, S. J. Chu, Y. J. Hung, and Y. F. Lin, “Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio,” Critical Care Medicine, vol. 34, no. 12, pp. 2984–2989, 2006.
- M. J. Hannon, L. A. Behan, and A. Agha, “Thyrotoxic periodic paralysis due to excessive L-thyroxine replacement in a Caucasian man,” Annals of Clinical Biochemistry, vol. 46, no. 5, pp. 423–425, 2009.
- H.-K. Chou, Y.-T. Tsao, and S.-H. Lin, “An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents,” The American Journal of the Medical Sciences, vol. 337, no. 1, pp. 71–73, 2009.
- T. Pappa, L. Papanastasiou, A. Markou et al., “Thyrotoxic periodic paralysis as the first manifestation of a thyrotropin-secreting pituitary adenoma,” Hormones, vol. 9, no. 1, pp. 82–86, 2010.
- G. T. C. Ko, C. C. Chow, V. T. F. Yeung, H. H. L. Chan, J. K. Y. Li, and C. S. Cockram, “Thyrotoxic periodic paralysis in a Chinese population,” QJM, vol. 89, no. 6, pp. 463–468, 1996.
- C. Boccalandro, L. Lopez, F. Boccalandro, and V. Lavis, “Electrocardiographic changes in thyrotoxic periodic paralysis,” The American Journal of Cardiology, vol. 91, no. 6, pp. 775–777, 2003.
- Y. Miyashita, T. Monden, K. Yamamoto et al., “Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis,” Internal Medicine, vol. 45, no. 1, pp. 11–13, 2006.
- S. A. Aldasouqi, S. A. Bokhari, P. M. Khan, and A. S. Al-Zahrani, “Thyrotoxic periodic paralysis in a Saudi patient complicated by life-threatening arrhythmia,” Saudi Medical Journal, vol. 30, no. 4, pp. 564–568, 2009.
- K. C. Lu, Y. J. Hsu, J. S. Chiu, Y. D. Hsu, and S. H. Lin, “Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis,” The American Journal of Emergency Medicine, vol. 22, no. 7, pp. 544–547, 2004.
- J. O. Levitt, “Practical aspects in the management of hypokalemic periodic paralysis,” Journal of Translational Medicine, vol. 6, article 18, 2008.
- H. Tassone, A. Moulin, and S. O. Henderson, “The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature,” Journal of Emergency Medicine, vol. 26, no. 2, pp. 157–161, 2004.
- S. H. Lin and Y. F. Lin, “Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis,” The American Journal of Kidney Diseases, vol. 37, no. 3, pp. 620–623, 2001.
- R. T. Yeung and T. F. Tse, “Thyrotoxic periodic paralysis: effect of propranolol,” The American Journal of Medicine, vol. 57, no. 4, pp. 584–590, 1974.
- S. Akar, A. Comlekci, M. Birlik et al., “Thyrotoxic periodic paralysis in a turkish male; the recurrence of the attack after radioiodine treatment,” Endocrine Journal, vol. 52, no. 1, pp. 149–151, 2005.
- D. P. Ryan, M. R. Dias da Silva, T. W. Soong et al., “Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis,” Cell, vol. 140, no. 1, pp. 88–98, 2010.